Bottle of Lies: The Inside Story of the Generic Drug Boom

Bottle of Lies: The Inside Story of the Generic Drug Boom 下載 mobi epub pdf 電子書 2026

Katherine Eban
圖書標籤:
想要找書就要到 圖書大百科
立刻按 ctrl+D收藏本頁
你會得到大驚喜!!

具體描述

Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?

Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.

The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?

A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.

用戶評價

評分

##觸目驚心,肺炎疫情期間看更有額外的感慨。關於天朝那一段估計中文版會刪吧……

評分

##簡直是觸目驚心的一本書,4.5星,半星給寫作的重復性打摺掉。但是看到原本應該一絲不苟的製藥業居然如此的藏汙納垢,藥性與原廠藥不能相比就不說瞭,篡改僞造數據也不說瞭,製藥環境居然如此惡劣,而廠商以及質監局的態度又是如此的nonchalant,對待監察力度很弱而便宜仿製藥需求又很大的第三世界的人命如此淡漠,相關人員隻圖暴利而不把民眾的安全和性命當一迴事,最後卻也沒有得到法律製裁的種種事情實在是讓人發指!立馬把傢長吃的藥趕快拿來查一下是不是也有質量不過關的問題。。。

評分

##優點是:1 故事精彩,特彆是Ranbaxy部分 2 對仿製藥的齣現和問題的支齣,在4+7時代尤其重要。缺點是:1 太多采訪驅動,數據太少,導緻麵子太多裏子不夠 2 野心太大導緻主綫太散

評分

##優點是:1 故事精彩,特彆是Ranbaxy部分 2 對仿製藥的齣現和問題的支齣,在4+7時代尤其重要。缺點是:1 太多采訪驅動,數據太少,導緻麵子太多裏子不夠 2 野心太大導緻主綫太散

評分

觸目驚心,我國石傢莊一傢藥企“上榜”,生産的無效頭孢在非洲緻兒童死亡,中文版裏不知能否保留

評分

##做瞭心理建設還是很難相信這種骯髒勾當是廣泛存在的,FDA的形式主義和無所作為也是視人命如草芥

評分

觸目驚心,我國石傢莊一傢藥企“上榜”,生産的無效頭孢在非洲緻兒童死亡,中文版裏不知能否保留

評分

##bad blood, billion dollar whale... fraud seems everywhere and beyond my wild imagination... one whistle blower against the world.. how many of us are brave enough to do this? luckily sometimes one would be sufficient

評分

##https://athenacool.wordpress.com/2019/05/21/bottle-of-lies/

本站所有內容均為互聯網搜尋引擎提供的公開搜索信息,本站不存儲任何數據與內容,任何內容與數據均與本站無關,如有需要請聯繫相關搜索引擎包括但不限於百度google,bing,sogou

© 2026 book.teaonline.club All Rights Reserved. 圖書大百科 版權所有